REMATIQ
PrivateLast Round
Seed
Apr 11, 2025
Total Funding Raised
$6.13M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
REMATIQ operates in Healthcare & Life Sciences and is based in Berlin. Its latest recorded funding round was a Seed round in April 2025.
REMATIQ is a MedTech company that provides an AI-native platform for automated product compliance designed to streamline regulatory processes for medical device companies.
Sector
Healthcare & Life Sciences
Verticals
Compliance & Risk, Medical Devices, RegTech, Workflow Automation, Document Management
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
REMATIQ Comparables
Compare REMATIQ with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Klaris | 88% | |
| RegDesk | 81% | |
| Ketryx | 76% |
For institutional investors. Book with your work email.
REMATIQ Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
REMATIQ Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amino Collective | Seed |
| Helloworld VC | Seed |
| Project A | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 31, 2026
Open roles increased to 20, 3.7x the trailing average.
- Aug 22, 2026
Monthly visitors grew 104% MoM, reaching 3.7K.
For institutional investors. Book with your work email.
REMATIQ Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about REMATIQ's valuation, stock price, and market status.
Is REMATIQ a public or private company?
REMATIQ is a private company.
What is the current stock price of REMATIQ?
REMATIQ is a private company, so its shares have no public market price. Caplight tracks REMATIQ's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is REMATIQ worth (valuation)?
Valuation information for REMATIQ is not publicly available.
Can I buy REMATIQ stock?
REMATIQ shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was REMATIQ's last funding round?
REMATIQ's most recent funding round was Seed on April 11, 2025.
Who are the main investors in REMATIQ?
Key investors in REMATIQ include Project A.
Will REMATIQ IPO soon?
No public IPO plans have been announced for REMATIQ.
How can I track REMATIQ secondary market activity?
Caplight tracks bids, offers, and trades in REMATIQ's shares on secondary markets.